Jakob Dupont, MD

The global head of research and development at Atara Biotherapeutics discussed ATA188 ahead of anticipated data readouts this month.

The global head of research and development at Atara Biotherapeutics discussed the future of MS research.

The global head of research and development at Atara Biotherapeutics discussed the link between EBV and MS.

The head of global research and executive vice president of Atara Biotherapeutics discussed the development of ATA188.

The executive vice president and head of global research and development at Atara Biotherapeutics spoke to the findings of a phase 1 study of the cell therapy ATA188.